Diagnostic Delays in Young Adults with Cancer: Contributing Factors and Implications

Author: Tolulope Adebile

Published on: 10/26/2024

 

Introduction
Recent research underscores a troubling trend: younger adults under 50 are more frequently diagnosed with advanced-stage cancers, particularly in types like colorectal cancer (CRC) and breast cancer (BC), compared to older adults. Studies reveal that diagnostic delays in this demographic arise from a complex interplay of patient and systemic factors, influenced by demographic, socioeconomic, and healthcare disparities (You et al., 2012; Castelo et al., 2023).
 

Key Findings in Colorectal Cancer and Breast Cancer 
Colorectal cancer provides a prominent example, where younger patients often face significant delays in diagnosis, increasing their likelihood of presenting with late-stage disease. For instance, an analysis of the National Cancer Database found that 63% of younger colon and 57% of younger rectal cancer patients presented with advanced disease—considerably higher than in older adults (You et al., 2012). Further supporting this trend, studies from the US and Canada (Kneuertz et al., 2015; Khan et al., 2016; Chen et al., 2016; Castelo et al., 2023) suggest that healthcare system structures, such as universal healthcare in Canada, may play a role in diagnosis timelines.

Breast cancer follows a similar pattern: young patients, especially from marginalized groups, show a higher incidence of late-stage diagnosis. For example, Indigenous women in Canada were found to be three times more likely to be diagnosed at advanced stages than their older counterparts (Decker et al., 2016).

Independent Risk Factors for Diagnostic Delays
Several factors contribute to diagnostic delays among young adult cancer patients:

1. Geographic and Age Disparities: Differences in healthcare systems impact diagnosis timelines. Universal healthcare systems, such as Canada’s, may enable earlier diagnosis than systems reliant on private insurance. In the US, young CRC and BC patients without insurance or on Medicaid are at higher risk for delayed diagnosis (You et al., 2012). Age also impacts risk, as younger adults face a greater likelihood of advanced-stage diagnosis—21% for those aged 30–39 and 40% for those aged 19–29—reflecting a broader trend of diagnostic delays in younger patients (You et al., 2012).

2. Racial Disparities: Young African Americans and other minority groups, such as Native Hawaiian or Pacific Islanders, exhibit an elevated risk for late-stage diagnosis (You et al., 2012; Rahman et al., 2015; Taparra et al., 2024). This disparity points to systemic inequalities intersecting with age and healthcare access, highlighting the need for targeted healthcare interventions.

3. Insurance and Access to Healthcare: Insurance coverage is critical in determining diagnosis timelines. As noted earlier, uninsured or publicly insured young patients face considerable diagnostic delays due to financial barriers and inconsistent care access (You et al., 2012).

4. Cancer Aggressiveness and Tumor Type: Younger adults frequently develop more aggressive cancer types, leading to faster progression and an increased likelihood of advanced-stage diagnosis, even when symptoms are detected early.

 

Patient and Provider-Related Delays
Diagnostic delays result from both patient and provider factors. Younger patients often delay seeking care due to fear, embarrassment, or practical barriers such as time constraints or limited health literacy (Siegel et al., 2020). Providers may also contribute to these delays by underestimating the likelihood of cancer in young patients, leading to less urgent referrals and repeated consultations (Siegel et al., 2020; Lyratzopoulos et al., 2012).

Conclusion
The data clearly demonstrates that younger adults are at an increased risk for delayed cancer diagnosis, which contributes to the progression to advanced disease stages by the time of detection. This trend is particularly pronounced among marginalized populations, who face compounded barriers due to socioeconomic and healthcare access disparities. Addressing these delays requires targeted healthcare policies and provider education to improve cancer outcomes for young adults.

Biblography

1. Castelo, M., Paszat, L., Hansen, B. E., Scheer, A. S., Faught, N., Nguyen, L., & Baxter, N. N. (2023). Comparing Time to Diagnosis and Treatment Between Younger and Older Adults With Colorectal Cancer: A Population-Based Study. Gastroenterology, 164(7), 1152–1164. https://doi.org/10.1053/j.gastro.2023.02.024 

2. Chen, F. W., Sundaram, V., Chew, T. A., & Ladabaum, U. (2017). Advanced-Stage Colorectal Cancer in Persons Younger Than 50 Years Not Associated With Longer Duration of Symptoms or Time to Diagnosis. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association, 15(5), 728–737.e3. https://doi.org/10.1016/j.cgh.2016.10.038  

3. Decker, K. M., Kliewer, E. V., Demers, A. A., Fradette, K., Biswanger, N., Musto, G., Elias, B., & Turner, D. (2016). Cancer incidence, mortality, and stage at diagnosis in First Nations living in Manitoba. Current oncology (Toronto, Ont.), 23(4), 225–232. https://doi.org/10.3747/co.23.2906 

4. Khan, S. A., Morris, M., Idrees, K., Gimbel, M. I., Rosenberg, S., Zeng, Z., Li, F., Gan, G., Shia, J., LaQuaglia, M. P., & Paty, P. B. (2016). Colorectal cancer in the very young: a comparative study of tumor markers, pathology and survival in early onset and adult onset patients. Journal of pediatric surgery, 51(11), 1812–1817. https://doi.org/10.1016/j.jpedsurg.2016.07.015  

5. Kneuertz, P. J., Chang, G. J., Hu, C. Y., Rodriguez-Bigas, M. A., Eng, C., Vilar, E., Skibber, J. M., Feig, B. W., Cormier, J. N., & You, Y. N. (2015). Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. JAMA surgery, 150(5), 402–409. https://doi.org/10.1001/jamasurg.2014.3572  

6. Lyratzopoulos, G., Neal, R. D., Barbiere, J. M., Rubin, G. P., & Abel, G. A. (2012). Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England. The Lancet. Oncology, 13(4), 353–365. https://doi.org/10.1016/S1470-2045(12)70041-4  

7. Rahman, R., Schmaltz, C., Jackson, C. S., Simoes, E. J., Jackson-Thompson, J., & Ibdah, J. A. (2015). Increased risk for colorectal cancer under age 50 in racial and ethnic minorities living in the United States. Cancer medicine, 4(12), 1863–1870. https://doi.org/10.1002/cam4.560  

8. Taparra, K., Kekumano, K., Benavente, R., Roberto, L., Gimmen, M., Shontell, R., ... & Pollom, E. (2024). Racial Disparities in Cancer Stage at Diagnosis and Survival for Adolescents and Young Adults. JAMA Network Open, 7(8), e2430975-e2430975. https://doi.org/10.1001/jamanetworkopen.2024.30975  

9. You, Y. N., Xing, Y., Feig, B. W., Chang, G. J., & Cormier, J. N. (2012). Young-onset colorectal cancer: is it time to pay attention?. Archives of internal medicine, 172(3), 287–289. https://doi.org/10.1001/archinternmed.2011.602